About: Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2007 (uk) im Mai 2007 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2007 (ast) scientific article published on 01 May 2007 (en)
publication date	wds:Q80238470-1DB64CA0-9923-411C-95CC-A4942B6020AE
publication date	2007-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80238470-04FE1CC1-5506-4278-85DE-8406C7BD51D2 wds:Q80238470-1B22C8B7-E91B-4B10-B270-BB6115D24BB6 wds:Q80238470-1C71518E-245D-4F82-BF9F-4E310B650D98 wds:Q80238470-2EA25EE7-33EC-4D8D-983B-753DA70A829D wds:Q80238470-335C4244-3B4F-4BE9-8E63-2E444A2ECC23 wds:Q80238470-3E7B0D81-E8B0-4CBC-9590-043D6D3ADAE7 wds:Q80238470-3FFA1CB7-6109-42B0-A2FD-795A4ED6E3D0 wds:Q80238470-431E2548-8663-4C64-91A1-C2CC7ABD609B wds:Q80238470-47A50D71-1392-48D9-BC4C-43CBC26EE931 wds:Q80238470-5095EB11-A4E6-46A7-AADD-B50E6A5836E6 wds:Q80238470-519B46CE-6CB5-4C85-A64A-E5F9EC623BE6 wds:Q80238470-55E920FA-AC60-4E1F-88F5-2FA782C734B5 wds:Q80238470-5E0FA3E8-BCED-460C-8CDF-C3FF05201FC8 wds:Q80238470-62C24DDA-AA94-499C-B0E5-0A29F73F4DE2 wds:Q80238470-79799FC4-DA7F-4FB8-8B12-06958B4427B0 wds:Q80238470-80B9322A-7E9E-4430-AF3A-BB259F40AAD2 wds:Q80238470-8F4CD149-A053-4B84-8BF9-26542B43D1A0 wds:Q80238470-A4EFF7DE-7472-4C90-8C17-BD1F02FE5DA0 wds:Q80238470-AD075B8A-020D-4BD2-ABE0-A91208ED9265 wds:Q80238470-B8BB08D7-D03C-4B02-9374-58A4A064A752 wds:Q80238470-E2F4CDF8-CFFE-499D-8EF1-1017233A050A wds:Q80238470-E470AD6D-DA05-4B05-B342-5F809FC4345F wds:Q80238470-E64C0C3F-457A-4EB0-9127-9B6669BEB566 wds:Q80238470-E6695D0F-816A-4BD7-A5DF-1B90647CBF14 wds:Q80238470-E79703E1-AE62-452F-9435-9EDEA4489E07 wds:Q80238470-F07248F5-E221-424D-B261-9E8085255F00 wds:Q80238470-F8BEC9C0-3D7E-48CC-A300-2BA16F5954C2 wds:Q80238470-F932CB3A-9F5F-4D0B-B4C1-8B8AC633EBF0
author name string	Dinesh Khanna James R Seibold John Varga Barri Fessler Xiaohong Yan Donald P Tashkin Charles Read Maureen Mayes Virginia Steen Daniel E Furst Philip J Clements Barbara White Michael D Roth Robert Elashoff Arthur Theodore Kamal Mubarak Mark Metersky Richard Silver Mitchell Olman Fredrick Wigley Jeffrey Golden M Kari Connolly Vivien M Hsu David J Riley Scleroderma Lung Study Group Marcy Bolster Naomi Rothfield Ed Parsley
rdfs:label	Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study (en) Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study (nl)
skos:prefLabel	Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study (en) Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study (nl)
name	Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study (en) Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study (nl)
author	wds:Q80238470-3A2E1394-72D5-49F9-8E84-03F97E496170 wds:Q80238470-90FDBAD5-A226-492F-BF6C-2D5374A2C649 wds:Q80238470-9673618A-CAB6-4149-A938-111D548DBC75 wds:Q80238470-C80D14A6-6836-4CB3-8A5C-9987B9E8C80A
author	Dean E Schraufnagel Robert A. Wise Robert Simms Charlie Strange
title	wds:Q80238470-55C61F92-79E7-445F-9C54-4D8BFCE1A830
title	Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study (en)
page(s)	wds:Q80238470-5D6D1C6F-F741-47F2-A012-99BA9C7B77E4
page(s)	1676-1684
instance of	wds:Q80238470-3E35DE43-EEDA-445B-9113-CD7CB920E2C8
instance of	scholarly article
main subject	wds:Q80238470-9F28E479-D661-44D2-96A0-EF98AB42FB34
main subject	lung disease
PubMed ID	wds:Q80238470-207A768E-466A-4563-B800-D2AB9E4DE4F1
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17469162
PubMed ID	17469162
published in	wds:Q80238470-BCC10C33-B131-4BA9-9423-9130C4CBDC3E
published in	Arthritis and Rheumatism
issue	wds:Q80238470-DBA6D3C3-75D0-421B-A25C-C8C996FB12A3
volume	wds:Q80238470-E3CB4BDD-6D45-4A6D-A9BC-8F5F4A1AB5A1
issue	5
volume	56
DOI	wds:Q80238470-3A112230-B240-4797-AB98-F3BD74D86C34
DOI	http://dx.doi.org/10.1002/ART.22580
DOI	10.1002/ART.22580
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80238470
is cites work of	Efficacy of rapamycin in scleroderma: a case study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software